A recent investigation by the FondaMental Expert Centers for Schizophrenia in France (FACE-SZ) revealed a potential immune signature associated with the IL-23/IL-17 pathway in treatment-resistant schizophrenia (95). This evidence concerns the gene IL17A and schizophrenia.